We have previously demonstrated that the release of arachidonic acid (AA) from human chorionic gonadotropin (hCG)-stimulated Leydig cells occurs in a dose- and time-dependent manner. In addition, the amount of AA released was dependent on the hormone-receptor interaction and the concentration of LH-hCG binding sites on the cell surface. The present study was conducted to evaluate the involvement of phospholipase A(2) (PLA(2)) and G proteins in AA release from hormonally stimulated rat Leydig cells, and the possible role of this fatty acid in cAMP production. Cells were first prelabelled with [(14)C]AA to incorporate the fatty acid into cell phospholipids, and then treated in different ways to evaluate AA release. hCG (25 mIU) increased the release of AA to 180+/-12% when compared with AA released from control cells, arbitrarily set as 100%. Mepacrine and parabromophenacyl bromide (pBpB), two PLA(2) inhibitors, decreased the hormone-stimulated AA release to 85+/-9 and 70+/-24% respectively. Conversely, melittin, a PLA(2) stimulator, increased the release of AA up to 200% over control. The inhibitory effect of mepacrine on the release of AA was evident in hCG-treated Leydig cells, but not in the melittin-treated cells. To determine if the release of AA was also mediated through a G protein, cells were first permeabilized and subsequently treated with pertussis toxin or GTPgammaS, a non-hydrolyzable analog of GTP. Results demonstrate that GTPgammaS was able to induce a similar level of the release of AA as hCG. In addition, pertussis toxin completely abolished the stimulatory effect of hCG on the release of AA, indicating that a member of the G(i) family was involved in the hCG-dependent release of AA. Cells treated with PLA(2) inhibitors did not modify cAMP production, but exogenously added AA significantly reduced cAMP production from hCG-treated Leydig cells, in a manner dependent on the concentration of AA and hCG. Results presented here suggest an involvement of PLA(2) and G proteins in the release of AA from hCG-stimulated Leydig cells, and under particular conditions, regulation of cAMP production by this fatty acid in these cells.

This article has been cited by other articles:

				X. Wang, X. Yin, R. B. Schiffer, S. R. King, D. M. Stocco, and P. Grammas Inhibition of Thromboxane A Synthase Activity Enhances Steroidogenesis and Steroidogenic Acute Regulatory Gene Expression in MA-10 Mouse Leydig Cells Endocrinology, February 1, 2008; 149(2): 851 - 857. [Abstract] [Full Text] [PDF]

				Z Cheng, E L Sheldrick, E Marshall, D C Wathes, D R E Abayasekara, and A P F Flint Control of cyclic AMP concentration in bovine endometrial stromal cells by arachidonic acid Reproduction, May 1, 2007; 133(5): 1017 - 1026. [Abstract] [Full Text] [PDF]

				H. Chen, L. Luo, J. Liu, and B. R. Zirkin Cyclooxygenases in Rat Leydig Cells: Effects of Luteinizing Hormone and Aging Endocrinology, February 1, 2007; 148(2): 735 - 742. [Abstract] [Full Text] [PDF]

				X. Wang, C.-L. Shen, M. T Dyson, X. Yin, R. B Schiffer, P. Grammas, and D. M Stocco The involvement of epoxygenase metabolites of arachidonic acid in cAMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression. J. Endocrinol., September 1, 2006; 190(3): 871 - 878. [Abstract] [Full Text] [PDF]

				D. M. Stocco, X. Wang, Y. Jo, and P. R. Manna Multiple Signaling Pathways Regulating Steroidogenesis and Steroidogenic Acute Regulatory Protein Expression: More Complicated than We Thought Mol. Endocrinol., November 1, 2005; 19(11): 2647 - 2659. [Abstract] [Full Text] [PDF]

				X. Wang, M. T. Dyson, Y. Jo, and D. M. Stocco Inhibition of Cyclooxygenase-2 Activity Enhances Steroidogenesis and Steroidogenic Acute Regulatory Gene Expression in MA-10 Mouse Leydig Cells Endocrinology, August 1, 2003; 144(8): 3368 - 3375. [Abstract] [Full Text] [PDF]